메뉴 건너뛰기




Volumn 35, Issue 3, 2008, Pages 96-103

Ecstasy (MDMA): Pharmacological and toxic effects, mechanism of action and clinical management;Êxtase (MDMA): Efeitos farmacológicos e tóxicos, mecanismo de ação e abordagem clínica

Author keywords

3,4 methylenedioxymethamphetamine; Drug abuse; Ecstasy; Intoxication; Neurotoxicity

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DIAZEPAM; FUROSEMIDE; LABETALOL; MANNITOL;

EID: 47749147716     PISSN: 01016083     EISSN: 1806938X     Source Type: Journal    
DOI: 10.1590/S0101-60832008000300002     Document Type: Review
Times cited : (9)

References (74)
  • 1
    • 0041466261 scopus 로고    scopus 로고
    • The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")
    • Green AR, mechan AO, Elliott JM, O'shea E, Colado MI. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev. 2003;55:463-508.
    • (2003) Pharmacol Rev , vol.55 , pp. 463-508
    • Green, A.R.1    mechan, A.O.2    Elliott, J.M.3    O'shea, E.4    Colado, M.I.5
  • 2
    • 34548331211 scopus 로고    scopus 로고
    • Um estudo sobre a psicodinâmica do usuário de ecstasy
    • Sardinha LS, Garcia AL. Um estudo sobre a psicodinâmica do usuário de ecstasy. Psicologia: teoria e prática. 2000;2(2):70-87.
    • (2000) Psicologia: Teoria e prática , vol.2 , Issue.2 , pp. 70-87
    • Sardinha, L.S.1    Garcia, A.L.2
  • 3
    • 12344323600 scopus 로고    scopus 로고
    • Ecstasy: Pharmacology and neurotoxicity
    • Morton J. Ecstasy: pharmacology and neurotoxicity. Curr Opin Pharmacol. 2005;5:79-86.
    • (2005) Curr Opin Pharmacol , vol.5 , pp. 79-86
    • Morton, J.1
  • 6
    • 0035664224 scopus 로고    scopus 로고
    • Canadian medical Association or its licensors
    • Kalante H. The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. Canadian medical Association or its licensors. 2001;165(7):917-28.
    • (2001) The pharmacology and toxicology of ecstasy , vol.165 , Issue.7 , pp. 917-928
    • Kalante, H.1
  • 8
    • 33846830016 scopus 로고    scopus 로고
    • Who is becoming hallucinogen dependent soon after hallucinogen use starts?
    • Stone AL, O'Brien MS, De la Torre A, Anthony JC. Who is becoming hallucinogen dependent soon after hallucinogen use starts? Drug Alcohol Depend. 2007;87(2/3):153-63.
    • (2007) Drug Alcohol Depend , vol.87 , Issue.2-3 , pp. 153-163
    • Stone, A.L.1    O'Brien, M.S.2    De la Torre, A.3    Anthony, J.C.4
  • 9
    • 33745214215 scopus 로고    scopus 로고
    • Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia
    • White B, Day C, Degenhardt L, Kinner S, Fry C, Bruno R, et al. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia. Drug Alcohol Depend. 2006;83(3):210-7.
    • (2006) Drug Alcohol Depend , vol.83 , Issue.3 , pp. 210-217
    • White, B.1    Day, C.2    Degenhardt, L.3    Kinner, S.4    Fry, C.5    Bruno, R.6
  • 10
    • 25144472627 scopus 로고    scopus 로고
    • Comparative study of drug use among undergraduate students at the University of Sao Paulo - Sao Paulo campus in 1996 and 2001
    • Stempliuk VA, Barroso LP, Andrade AG, Nicastri S, Malbergier A. Comparative study of drug use among undergraduate students at the University of Sao Paulo - Sao Paulo campus in 1996 and 2001. Rev Bras Psiquiatr. 2005;27(3):185-93.
    • (2005) Rev Bras Psiquiatr , vol.27 , Issue.3 , pp. 185-193
    • Stempliuk, V.A.1    Barroso, L.P.2    Andrade, A.G.3    Nicastri, S.4    Malbergier, A.5
  • 11
    • 4243586451 scopus 로고    scopus 로고
    • Polícia fecha laboratório de ecstasy em São Paulo
    • Sec. C1
    • Silva A. Polícia fecha laboratório de ecstasy em São Paulo. Folha de São Paulo. 2000, Sec. C1.
    • (2000) Folha de São Paulo
    • Silva, A.1
  • 12
    • 19544391657 scopus 로고    scopus 로고
    • O uso de êxtase (MDMA) na cidade de São Paulo e imediações: Um estudo etnográfico.
    • Baptista MC, Noto AR, Carlini EA. O uso de êxtase (MDMA) na cidade de São Paulo e imediações: Um estudo etnográfico. J Bras Psiquiatria. 2002;51:81-9.
    • (2002) J Bras Psiquiatria , vol.51 , pp. 81-89
    • Baptista, M.C.1    Noto, A.R.2    Carlini, E.A.3
  • 13
    • 0037353136 scopus 로고    scopus 로고
    • Ecstasy (MDMA): Effects and patterns of use reported by users in Sao Paulo
    • Almeida SP, Silva MTA. Ecstasy (MDMA): effects and patterns of use reported by users in Sao Paulo. Rev Bras Psiquiatria. 2003;25(1):11-7.
    • (2003) Rev Bras Psiquiatria , vol.25 , Issue.1 , pp. 11-17
    • Almeida, S.P.1    Silva, M.T.A.2
  • 14
    • 0031253720 scopus 로고    scopus 로고
    • MDMA (ecstasy) and the rave: A review
    • Schwartz RH, Miller NS. MDMA (ecstasy) and the rave: a review. Pediatrics. 1997;100(4):705-8.
    • (1997) Pediatrics , vol.100 , Issue.4 , pp. 705-708
    • Schwartz, R.H.1    Miller, N.S.2
  • 15
    • 0028292728 scopus 로고
    • 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): Pharmacology and toxicology in animals and humans
    • Steele TD, Mccann UD, Ricaurte GA. 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): pharmacology and toxicology in animals and humans. Addiction. 1994;89:539-51.
    • (1994) Addiction , vol.89 , pp. 539-551
    • Steele, T.D.1    Mccann, U.D.2    Ricaurte, G.A.3
  • 18
    • 47749112196 scopus 로고    scopus 로고
    • Mascaró BI, Aznar BA, Serrano GJ, Lopez-Briz E, Martini-Bonmati E. MDMA Extasis: Revisión y puesta al día. Rev Esp Drogodep. 1991;16(2):91-101.
    • Mascaró BI, Aznar BA, Serrano GJ, Lopez-Briz E, Martini-Bonmati E. MDMA "Extasis": Revisión y puesta al día. Rev Esp Drogodep. 1991;16(2):91-101.
  • 20
    • 2542629618 scopus 로고    scopus 로고
    • Bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities
    • Schifano FA. Bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Psychopharmacol. 2004;173:242-8.
    • (2004) Psychopharmacol , vol.173 , pp. 242-248
    • Schifano, F.A.1
  • 21
    • 0034092057 scopus 로고    scopus 로고
    • Identification of the human cytochromes P450 involved in the oxidative metabolism of Ecstasy related designer grugs
    • Kreth K, Kovar K, Schwab M, Zanger UM. Identification of the human cytochromes P450 involved in the oxidative metabolism of Ecstasy related designer grugs. Biochem Pharmacol. 2000;59:1563 -71.
    • (2000) Biochem Pharmacol , vol.59 , pp. 1563-1571
    • Kreth, K.1    Kovar, K.2    Schwab, M.3    Zanger, U.M.4
  • 22
    • 0346639257 scopus 로고    scopus 로고
    • Ecstasy: Pharmacodynamic and pharmacokinetic interactions
    • Oesterheld JR, Armstrong SC, Cozza KL. Ecstasy: pharmacodynamic and pharmacokinetic interactions. Psychosomatics. 2004;45:84-7.
    • (2004) Psychosomatics , vol.45 , pp. 84-87
    • Oesterheld, J.R.1    Armstrong, S.C.2    Cozza, K.L.3
  • 23
    • 0037096036 scopus 로고    scopus 로고
    • Reduced 3,4-methylenedioxymethamphetamine (ecstasy) metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro
    • Ramamoorthy Y, Yu Am, Suh N, Haining RL, Tyndale RF, Sellers EM. Reduced 3,4-methylenedioxymethamphetamine (ecstasy) metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro. Biochem Pharmacol. 2002;3:2111-9.
    • (2002) Biochem Pharmacol , vol.3 , pp. 2111-2119
    • Ramamoorthy, Y.1    Yu, A.2    Suh, N.3    Haining, R.L.4    Tyndale, R.F.5    Sellers, E.M.6
  • 24
    • 0032576351 scopus 로고    scopus 로고
    • Fatal interaction between ritonavir and MDMA
    • Henry J, Hill IR. Fatal interaction between ritonavir and MDMA. Lancet. 1998;28:1751-2.
    • (1998) Lancet , vol.28 , pp. 1751-1752
    • Henry, J.1    Hill, I.R.2
  • 25
    • 0033778086 scopus 로고    scopus 로고
    • Ecstasy (MDMA): A review of its possible persistent psychological effects
    • Morgan MJ. Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacol. 2000;152:230-48.
    • (2000) Psychopharmacol , vol.152 , pp. 230-248
    • Morgan, M.J.1
  • 26
    • 0026716102 scopus 로고
    • Phenomenology and sequelae of 3,4-methylenedimethoxymethamphetamine use
    • Liester M, Grob C, Bravo G. Phenomenology and sequelae of 3,4-methylenedimethoxymethamphetamine use. J Nerv ment Dis. 1992;180:345-52.
    • (1992) J Nerv ment Dis , vol.180 , pp. 345-352
    • Liester, M.1    Grob, C.2    Bravo, G.3
  • 27
    • 0022834268 scopus 로고
    • MDMA nonmedical use and intoxication
    • Siegel RK. MDMA nonmedical use and intoxication. J Psychoactive Drugs. 1986;18(4):349-54.
    • (1986) J Psychoactive Drugs , vol.18 , Issue.4 , pp. 349-354
    • Siegel, R.K.1
  • 28
    • 0033660972 scopus 로고    scopus 로고
    • Acute psychosis with agressive behavior as a consequence of MDMA (ecstasy) consumption
    • Milas M. Acute psychosis with agressive behavior as a consequence of MDMA (ecstasy) consumption. Lijec Vjesn. 2000;122(1-2):27-30.
    • (2000) Lijec Vjesn , vol.122 , Issue.1-2 , pp. 27-30
    • Milas, M.1
  • 29
    • 0025863667 scopus 로고
    • Lasting neuropsychiatric sequelae of methylenedioxymethamphetamine ("ecstasy") in recreational users
    • Mccann U, Ricaurte G. Lasting neuropsychiatric sequelae of methylenedioxymethamphetamine ("ecstasy") in recreational users. J Clin Psychopharmacol. 1991;11:302-5.
    • (1991) J Clin Psychopharmacol , vol.11 , pp. 302-305
    • Mccann, U.1    Ricaurte, G.2
  • 30
    • 0026073632 scopus 로고
    • Chronic paranoid psychosis after misure of MDMA ("ecstasy")
    • Mcguire P, Fahy T. Chronic paranoid psychosis after misure of MDMA ("ecstasy"). BMJ. 1991;302:697.
    • (1991) BMJ , vol.302 , pp. 697
    • Mcguire, P.1    Fahy, T.2
  • 31
    • 0033921470 scopus 로고    scopus 로고
    • Potential human neurotoxicity of MDMA ("ecstasy"): Subjective self-reports, evidence from an Italian drug addicition centre and clinical case studies
    • Schifano F. Potential human neurotoxicity of MDMA ("ecstasy"): subjective self-reports, evidence from an Italian drug addicition centre and clinical case studies. Neuropsychobiol. 2000;42(1):25-33.
    • (2000) Neuropsychobiol , vol.42 , Issue.1 , pp. 25-33
    • Schifano, F.1
  • 32
    • 0029846728 scopus 로고    scopus 로고
    • Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy")
    • Mccann UD, Slate SO, Ricaurte GA. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy"). Drug Safety. 1996;15:107-15.
    • (1996) Drug Safety , vol.15 , pp. 107-115
    • Mccann, U.D.1    Slate, S.O.2    Ricaurte, G.A.3
  • 35
    • 0029067178 scopus 로고    scopus 로고
    • Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy")
    • Green AR, Cross AJ, Goodwin GM. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"). Psychopharmacol. 1996;119:247-60.
    • (1996) Psychopharmacol , vol.119 , pp. 247-260
    • Green, A.R.1    Cross, A.J.2    Goodwin, G.M.3
  • 36
    • 4143152622 scopus 로고    scopus 로고
    • Human pharmacology of MDMA: Pharmacokinetics, metabolism and disposition
    • De la Torre R, Farre M, Roset PN, et al. Human pharmacology of MDMA: pharmacokinetics, metabolism and disposition. Ther Drug Monit. 2004;26:137-44.
    • (2004) Ther Drug Monit , vol.26 , pp. 137-144
    • De la Torre, R.1    Farre, M.2    Roset, P.N.3
  • 37
    • 0027278178 scopus 로고
    • Effects of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity
    • Brodkin J, Malyala A, Nash JF. Effects of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity. Pharmacol Biochem Behav. 1993;45:647-53.
    • (1993) Pharmacol Biochem Behav , vol.45 , pp. 647-653
    • Brodkin, J.1    Malyala, A.2    Nash, J.F.3
  • 38
    • 0028104042 scopus 로고
    • MDMA (ecstasy) inhibition of MAO type A and type B: Comparisons with fenfluramine and fluoxetine (Prozac)
    • Leonardi ET, Azmitia EC. MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac). Neuropsychopharmacol. 1994;10:231-8.
    • (1994) Neuropsychopharmacol , vol.10 , pp. 231-238
    • Leonardi, E.T.1    Azmitia, E.C.2
  • 39
    • 4243561090 scopus 로고    scopus 로고
    • Evidence against MDMA-induced hyperthermia being mediated by 5-HT release in the brain
    • Mechan AO, Colado MI, Esteban B, Elliott JM, Green AR. Evidence against MDMA-induced hyperthermia being mediated by 5-HT release in the brain. Br J Pharmacol. 2000;131:153.
    • (2000) Br J Pharmacol , vol.131 , pp. 153
    • Mechan, A.O.1    Colado, M.I.2    Esteban, B.3    Elliott, J.M.4    Green, A.R.5
  • 40
    • 0023735752 scopus 로고
    • Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: Immunocytochemical evidence for neurotoxicity
    • O'Hearn E, Battaglia G, Souza EB, Kuhar MJ, Molliver ME. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci. 1988;8:2788-803.
    • (1988) J Neurosci , vol.8 , pp. 2788-2803
    • O'Hearn, E.1    Battaglia, G.2    Souza, E.B.3    Kuhar, M.J.4    Molliver, M.E.5
  • 41
    • 0023475168 scopus 로고
    • Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine
    • Schmidt CJ, Taylor VL. Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine. Biochem Pharmacol. 1987;36:4095-5102.
    • (1987) Biochem Pharmacol , vol.36 , pp. 4095-5102
    • Schmidt, C.J.1    Taylor, V.L.2
  • 42
    • 0026296836 scopus 로고
    • Ecstasy: Towards an understanding of the biochemical basis of the actions of MDMA
    • Rattray M. Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA. Essays Biochem. 1991;26:77-87.
    • (1991) Essays Biochem , vol.26 , pp. 77-87
    • Rattray, M.1
  • 43
    • 0030660459 scopus 로고    scopus 로고
    • Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4- methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners
    • Huether G, Zhou D, Ruther E. Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4- methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners. J Neural Transm (Budapest). 1997;104(8-9):771-94.
    • (1997) J Neural Transm (Budapest) , vol.104 , Issue.8-9 , pp. 771-794
    • Huether, G.1    Zhou, D.2    Ruther, E.3
  • 45
    • 30644457692 scopus 로고    scopus 로고
    • Role of alpha 2A-adrenoceptors in the effects of MDMA on body temperature in the mouse
    • Bexis S, Docherty JR. Role of alpha 2A-adrenoceptors in the effects of MDMA on body temperature in the mouse. Br J Pharmacol. 2005;145:1-6.
    • (2005) Br J Pharmacol , vol.145 , pp. 1-6
    • Bexis, S.1    Docherty, J.R.2
  • 46
    • 0032585937 scopus 로고    scopus 로고
    • Investigation of the prejunctional α2 adrenoceptor mediated actions of MDMA in rat atrium and vas deferens
    • Lavelle A, Honner V, Docherty JR. Investigation of the prejunctional α2 adrenoceptor mediated actions of MDMA in rat atrium and vas deferens. Br J Pharmacol. 1999;128:975-80.
    • (1999) Br J Pharmacol , vol.128 , pp. 975-980
    • Lavelle, A.1    Honner, V.2    Docherty, J.R.3
  • 47
    • 0034762682 scopus 로고    scopus 로고
    • Vascular actions of MDMA involve α1 and α2 adrenoceptors in the anaesthetized rat
    • McDaid J, Docherty JR. Vascular actions of MDMA involve α1 and α2 adrenoceptors in the anaesthetized rat. Br J Pharmacol. 2001;133:429-37.
    • (2001) Br J Pharmacol , vol.133 , pp. 429-437
    • McDaid, J.1    Docherty, J.R.2
  • 48
    • 0034090539 scopus 로고    scopus 로고
    • MDMA ("ecstasy") enhances basal acetylcholine release in brain slices of the rat striatum
    • Fischer HS, Zerning G, Schatz DS, Humpel C, Saria A. MDMA ("ecstasy") enhances basal acetylcholine release in brain slices of the rat striatum. Eur J Neurosci. 2000;12(4):1385-90.
    • (2000) Eur J Neurosci , vol.12 , Issue.4 , pp. 1385-1390
    • Fischer, H.S.1    Zerning, G.2    Schatz, D.S.3    Humpel, C.4    Saria, A.5
  • 49
    • 0034690772 scopus 로고    scopus 로고
    • MDMA (Ecstasy) neurotoxicity: Assessing and communicating the risks
    • Boot BP, McGregor IS, Hall W. MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks. Lancet. 2000;355:1818-21.
    • (2000) Lancet , vol.355 , pp. 1818-1821
    • Boot, B.P.1    McGregor, I.S.2    Hall, W.3
  • 50
    • 0032985047 scopus 로고    scopus 로고
    • Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ("ecstasy") users
    • Semple DM, Ebmeier KP, Glabus MF, O'Carroll RE, Johnstone EC. Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ("ecstasy") users. Br J Psychiatry. 1999;175:63-9.
    • (1999) Br J Psychiatry , vol.175 , pp. 63-69
    • Semple, D.M.1    Ebmeier, K.P.2    Glabus, M.F.3    O'Carroll, R.E.4    Johnstone, E.C.5
  • 51
  • 52
    • 0036123041 scopus 로고    scopus 로고
    • How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?
    • Kish SJ. How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? Pharmacol Biochem Behav. 2002;71:845-55.
    • (2002) Pharmacol Biochem Behav , vol.71 , pp. 845-855
    • Kish, S.J.1
  • 53
    • 0030986255 scopus 로고    scopus 로고
    • In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA (ecstasy) and p-chloroamphetamine but not the degeneration following fenfluramine
    • Colado MI, O'Shea E, Granados R, Murray TK, Green AR. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA (ecstasy) and p-chloroamphetamine but not the degeneration following fenfluramine. Br J Pharmacol. 1997;21:889-900.
    • (1997) Br J Pharmacol , vol.21 , pp. 889-900
    • Colado, M.I.1    O'Shea, E.2    Granados, R.3    Murray, T.K.4    Green, A.R.5
  • 54
    • 0032763755 scopus 로고    scopus 로고
    • Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine
    • Shankaran M, Yamamoto BK, Gudelsky GA. Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine. Eur J Pharmacol. 1999;385:103-10.
    • (1999) Eur J Pharmacol , vol.385 , pp. 103-110
    • Shankaran, M.1    Yamamoto, B.K.2    Gudelsky, G.A.3
  • 55
    • 0029078456 scopus 로고
    • The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits
    • Sprague JE, Nichols DE. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits. J Pharmacol Exp Ther. 1995;273:667-73.
    • (1995) J Pharmacol Exp Ther , vol.273 , pp. 667-673
    • Sprague, J.E.1    Nichols, D.E.2
  • 56
    • 0035123882 scopus 로고    scopus 로고
    • Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT
    • Shankaran M, Yamamoto BK, Gudelsky GA. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT. Synapse. 2001;40:55-64.
    • (2001) Synapse , vol.40 , pp. 55-64
    • Shankaran, M.1    Yamamoto, B.K.2    Gudelsky, G.A.3
  • 57
    • 0031847891 scopus 로고    scopus 로고
    • Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice
    • Ali SF, Itzhak Y. Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice. Ann NY Acad Sci. 1998;844:122-30.
    • (1998) Ann NY Acad Sci , vol.844 , pp. 122-130
    • Ali, S.F.1    Itzhak, Y.2
  • 58
    • 0035679302 scopus 로고    scopus 로고
    • A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on dopamine neurons in mouse brain
    • Colado MI, Camarero J, Mechan AO, Sanchez V, Esteban B, Elliott JM et al. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on dopamine neurons in mouse brain. Br J Pharmacol. 2001;134:1711-23.
    • (2001) Br J Pharmacol , vol.134 , pp. 1711-1723
    • Colado, M.I.1    Camarero, J.2    Mechan, A.O.3    Sanchez, V.4    Esteban, B.5    Elliott, J.M.6
  • 59
    • 0029002294 scopus 로고
    • Involvement of oxidative and L-arginine NO pathways in the neurotoxicity of drugs of abuse in vitro
    • Cerruti C, Sheng P, Ladenheim B, Esptien CJ, Cadet JL. Involvement of oxidative and L-arginine NO pathways in the neurotoxicity of drugs of abuse in vitro. Clin Exp Pharmacol Physiol. 1995;22:381-2.
    • (1995) Clin Exp Pharmacol Physiol , vol.22 , pp. 381-382
    • Cerruti, C.1    Sheng, P.2    Ladenheim, B.3    Esptien, C.J.4    Cadet, J.L.5
  • 60
    • 0026466921 scopus 로고
    • Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome: a multicenter report
    • Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol. 1992;20:1391-6.
    • (1992) J Am Coll Cardiol , vol.20 , pp. 1391-1396
    • Brugada, P.1    Brugada, J.2
  • 61
    • 0036312489 scopus 로고    scopus 로고
    • Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") ingestion
    • Hartung TK, Schofield E, Short AL, Parr MJA, Henry JA. Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") ingestion. Q J Med. 2002;95:431-7.
    • (2002) Q J Med , vol.95 , pp. 431-437
    • Hartung, T.K.1    Schofield, E.2    Short, A.L.3    Parr, M.J.A.4    Henry, J.A.5
  • 62
    • 0036131275 scopus 로고    scopus 로고
    • Drugs of abuse monitoring in blood for control of driving under the influence of drugs. Special toxicology issue
    • Moeller MR, Kraemer T. Drugs of abuse monitoring in blood for control of driving under the influence of drugs. Special toxicology issue. Ther Drug Monitor. 2002; 24(2):210-21.
    • (2002) Ther Drug Monitor , vol.24 , Issue.2 , pp. 210-221
    • Moeller, M.R.1    Kraemer, T.2
  • 64
    • 0026680529 scopus 로고
    • Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")
    • Henry J, Jeffreys K, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet. 1992;340:384-7.
    • (1992) Lancet , vol.340 , pp. 384-387
    • Henry, J.1    Jeffreys, K.2    Dawling, S.3
  • 66
    • 33646871323 scopus 로고    scopus 로고
    • Acute toxic effects of "Ecstasy" (MDMA) and related compounds: Overview of pathophysiology and clinical management
    • Hall AP, Henry JA. Acute toxic effects of "Ecstasy" (MDMA) and related compounds: overview of pathophysiology and clinical management. British Journal of Anaesthesia. 2006;96(6):678-85.
    • (2006) British Journal of Anaesthesia , vol.96 , Issue.6 , pp. 678-685
    • Hall, A.P.1    Henry, J.A.2
  • 67
    • 0029881804 scopus 로고    scopus 로고
    • Near-fatal hyponatraemic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA)
    • Holden R, Jackson MA. Near-fatal hyponatraemic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA). Lancet. 1996;347:1052.
    • (1996) Lancet , vol.347 , pp. 1052
    • Holden, R.1    Jackson, M.A.2
  • 68
    • 26444511151 scopus 로고    scopus 로고
    • Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity
    • Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth. 2005;95:434-41.
    • (2005) Br J Anaesth , vol.95 , pp. 434-441
    • Gillman, P.K.1
  • 69
    • 0035170740 scopus 로고    scopus 로고
    • Pathophysiological role of the serotonin system in malignant hyperthermia
    • Wappler F, Fiege M, Schulte AM, Esch F. Pathophysiological role of the serotonin system in malignant hyperthermia. Br J Anaesth. 2001;87:794-8.
    • (2001) Br J Anaesth , vol.87 , pp. 794-798
    • Wappler, F.1    Fiege, M.2    Schulte, A.M.3    Esch, F.4
  • 70
    • 0030040183 scopus 로고    scopus 로고
    • Pathology of deaths associated with "ecstasy" and "eve" missue
    • Milroy CM, Clark JC, Forrest ARW. Pathology of deaths associated with "ecstasy" and "eve" missue. J Clin Pathol. 1996;49:149-53.
    • (1996) J Clin Pathol , vol.49 , pp. 149-153
    • Milroy, C.M.1    Clark, J.C.2    Forrest, A.R.W.3
  • 71
    • 0026684873 scopus 로고
    • Ecstasy and the dance of death
    • Henry J. Ecstasy and the dance of death. BMJ. 1992;305:5-6.
    • (1992) BMJ , vol.305 , pp. 5-6
    • Henry, J.1
  • 72
    • 47749140162 scopus 로고    scopus 로고
    • United Kingdom national Poisons Information Service Guidelines, cited 2007 Sep 3, Available from
    • United Kingdom national Poisons Information Service Guidelines. [cited 2007 Sep 3]. Available from http://www.npis.org
  • 73
    • 47749143775 scopus 로고    scopus 로고
    • Pharmacologic advances in emergency medicine. New drugs of abuse - 3,4-methylenedioxymethamphetamine
    • Graeme KA. Pharmacologic advances in emergency medicine. New drugs of abuse - 3,4-methylenedioxymethamphetamine. Emergency Medicine Clinics of North America. 2000;18(4).
    • (2000) Emergency Medicine Clinics of North America , vol.18 , Issue.4
    • Graeme, K.A.1
  • 74
    • 0023819569 scopus 로고
    • 3,4-methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates
    • Ricaurte GA, Forno LS, Wilson MA, DeLanney LE, Irwin I, Molliver ME, et al. 3,4-methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. JAMA. 1988;260(1):51-5.
    • (1988) JAMA , vol.260 , Issue.1 , pp. 51-55
    • Ricaurte, G.A.1    Forno, L.S.2    Wilson, M.A.3    DeLanney, L.E.4    Irwin, I.5    Molliver, M.E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.